Answer: A
Explanation:
"That's what evolution is all about: tiny changes in organisms of a species over a huge amount of time."
This includes all animals apart from the subphylum Vertebrata. Familiar examples of invertebrates include insects; crabs, lobsters and their kin; snails, clams, octopuses and their kin; starfish, sea-urchins and their kin; and worms. The majority of animal species are invertebrates; one estimate puts the figure at 97%.
DNA, or deoxyribonucleic acid, is the hereditary material in humans and almost all other organisms. Nearly every cell in a person's body has the same DNA
DNA sequencing refers to the general laboratory technique for determining the exact sequence of nucleotides, or bases, in a DNA molecule
5' AAATGTCCATGC 3'
3' -TTACAGGTACG -5' is the sequence and polarity of the dna strand complementary to the strand 5' aaatgtccatgc 3'.
To know more about DNA sequence here
brainly.com/question/14923432
#SPJ4
Answer:
Embryo cell or totipotent cell
Explanation:
All organisms during their embryonic stage also known as totipotent cells are composed of cells that are identical in structure and function. These cells can differentiate at a later stage and have the potential to become any cell i.e heart cell, eye cell etc. Embryo is thus just a mass of unspecialized cell which undergo differentiation to then convert into pluripotent and form tissues and hence the organ.
Answer:
1) The genetic changes can lead to a reduction in the capacity of the mice to move glycogen at its branches points and lowers blood glucose levels between meals.
2) Genetic changed can lead to a decrease in the capacity to lower blood glucose due to the knock out of the hexokinase gene leading to elevated levels in the bloodstream.
(c) A knockout of FBPase2 will result in elevated levels of fructose-2,6-bisphosphate in
liver favoring the glycolytic pathway and inhibiting gluconeogenesis by the decrease of fructose 1,6-
bisphosphatase-1 activity
(d) An active FBPase-2 will now favor gluconeogenesis and this inhibits glycolysis. I.e. a decrease in PFK-1 activity while increasing FBPase-1 activity simultaneously.
